Cadrenal Therapeutics (CVKD) Earnings Date, Estimates & Call Transcripts → How Biden has already won 2024 (From Porter & Company) (Ad) Free CVKD Stock Alerts $0.49 +0.01 (+2.08%) (As of 05/8/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 11EstimatedActual EPS (Mar. 11) -$0.05 Beat By $0.04 Consensus EPS (Mar. 11) -$0.09 Get Cadrenal Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CVKD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCVKD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CVKD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. Cadrenal Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.09)($0.09)($0.09)Q2 20241($0.18)($0.18)($0.18)Q3 20241($0.17)($0.17)($0.17)Q4 20241($0.22)($0.22)($0.22)FY 20244($0.66)($0.66)($0.66)CVKD Earnings Date and InformationCadrenal Therapeutics last issued its earnings data on March 11th, 2024. The reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.04. Cadrenal Therapeutics has generated ($0.69) earnings per share over the last year (($0.69) diluted earnings per share). Earnings for Cadrenal Therapeutics are expected to grow in the coming year, from ($0.34) to ($0.31) per share. Read More Cadrenal Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/11/2024Q4 2023($0.09)($0.05)+$0.04($0.05)--11/9/2023Q3 2023-($0.07)($0.07)($0.07)--8/10/2023Q2 2023-($0.09)($0.09)($0.09)--5/10/2023Q1 2023-($0.41)($0.41)($0.34)-- Cadrenal Therapeutics Earnings - Frequently Asked Questions When did Cadrenal Therapeutics announce their last quarterly earnings? Cadrenal Therapeutics (NASDAQ:CVKD) last announced its quarterly earning data on Monday, March 11, 2024. Learn more on CVKD's earnings history. Did Cadrenal Therapeutics beat their earnings estimates last quarter? In the previous quarter, Cadrenal Therapeutics (NASDAQ:CVKD) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.09) by $0.04. Learn more on analysts' earnings estimate vs. CVKD's actual earnings. How much profit does Cadrenal Therapeutics generate each year? Cadrenal Therapeutics (NASDAQ:CVKD) has a recorded net income of -$8.36 million. CVKD has generated -$0.69 earnings per share over the last four quarters. What is Cadrenal Therapeutics's EPS forecast for next year? Cadrenal Therapeutics's earnings are expected to grow from ($0.34) per share to ($0.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Virios Therapeutics Earnings Trevena Earnings NuCana Earnings Biofrontera Earnings Cyclerion Therapeutics Earnings Vaccinex Earnings eFFECTOR Therapeutics Earnings Hepion Pharmaceuticals Earnings Pasithea Therapeutics Earnings Can-Fite BioPharma Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:CVKD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
